Abstract
In March of 2020 our team of researchers developed and opened three clinical trials to investigate hydroxychloroquine as prophylaxis or treatment for the coronavirus disease 2019 (COVID-19). We simultaneously built corresponding Research Electronic Data Capture (REDCap) projects for these low-touch, remote trials that relied on participant-reported data. REDCap has built-in features that support pragmatic, internet-based studies, and REDCap is flexible enough to allow creative solutions for specific trials. We describe challenges, choices, and suggestions based on our experience with REDCap for our COVID-19 trials.
Original language | English (US) |
---|---|
Article number | 106660 |
Journal | Contemporary Clinical Trials |
Volume | 114 |
DOIs | |
State | Published - Mar 2022 |
Bibliographical note
Publisher Copyright:© 2022 Elsevier Inc.
Keywords
- Automation
- Clinical trials
- Covid-19
- Data base management
- Patient-oriented research
- Survey